DNA Damage
-
CUDC-101
Catalog No. A10246 -
ITF2357 (Givinostat)
Catalog No. A10488 -
Droxinostat
Catalog No. A10337 HDAC 抑制剂Droxinostat是HDAC3,HDAC6和HDAC8的选择性抑制剂,显示出可比较的HDAC6和HDAC8抑制作用,IC50分别为2.47和1.46μmol/ L。 了解更多 -
PCI-24781 (Abexinostat)
Catalog No. A10700 -
Tubastatin A HCl
Catalog No. A11042 HDAC6 抑制剂Tubastatin A HCl是一种有效的选择性HDAC6抑制剂,在无细胞试验中IC50为15 nM。它对除HDAC8(57倍)以外的所有其他同工酶(1000倍)具有选择性。 了解更多 -
Pyroxamide (NSC 696085)
Catalog No. A10764 HDAC 抑制剂Pyroxamide (NSC 696085)是亲和纯化的HDAC1的有效抑制剂,可导致乙酰化核心组蛋白在用该试剂培养的MEL细胞中积累。 了解更多 -
PCI-34051
Catalog No. A11152 -
Parthenolide ((-)-Parthenolide)
Catalog No. A10698 Parthenolide ((-)-Parthenolide), Nuclear Factor-κB抑制剂,可特异性地耗尽HDAC1蛋白,而不影响其他I/II类 HDACs。促进MDM2的泛素化并激活p53的细胞功能。 了解更多 -
LAQ824 (NVP-LAQ824, Dacinostat)
Catalog No. A10516 HDAC 抑制剂LAQ824 (NVP-LAQ824)是一种有效的新型组蛋白去乙酰化酶抑制剂,具有显著的抗多发性骨髓瘤活性。 了解更多 -
ACY-1215 (Rocilinostat)
Catalog No. A11940 HDAC6 抑制剂ACY-1215 (Rocilinostat)是一种选择性HDAC6抑制剂,从而通过Hsp90的超乙酰化作用破坏Hsp90蛋白伴侣系统,并防止随后的总蛋白降解。 了解更多 -
CI994 (Tacedinaline)
Catalog No. A11964 -
RGFP966
Catalog No. A13218 -
Resminostat
Catalog No. A12556 HDAC 抑制剂Resminostat,也称为RAS2410,是一种有效的I和II类组蛋白脱乙酰基酶(HDAC)抑制剂。它结合并抑制HDAC,从而导致高度乙酰化的组蛋白的积累。选择性的抑制HDAC1/3/6,IC50为42.5 nM/50.1 nM/71.8 nM,作用于HDAC8效果弱,IC50为877 nM。 了解更多 -
Nexturastat A
Catalog No. A14032 HDAC6 抑制剂Nexturastat A是一种芳基脲衍生物,可作为组蛋白脱乙酰基酶6(HDAC6)的有效且高度选择性的抑制剂(IC50 = 5.02+/-0.60 nM)。 了解更多 -
Splitomicin
Catalog No. A14221 NAD(+)-dependent histone deacetylase Sir2p 抑制剂Splitomicin是一种选择性的NAD(+)-依赖性组蛋白脱乙酰基酶Sir2p抑制剂,IC50为60 uM,在基于细胞的测定中显示出更高的活性。 了解更多 -
Tasquinimod
Catalog No. A12616 -
Santacruzamate A
Catalog No. A14236 HDAC 抑制剂Santacruzamate A (CAY10683)是一种有效的选择性HDAC抑制剂,对HDAC2的IC50为119 pM,选择性是其他HDAC的3600倍以上。 了解更多 -
LMK-235
Catalog No. A14341 -
Domatinostat (4SC-202)
Catalog No. A14354 -
BRD73954
Catalog No. A15489 -
CAY10603
Catalog No. A16431 -
SR-4370
Catalog No. A16899 -
HDAC8-IN-1
Catalog No. A17091 -
Tinostamustine (EDO-S101)
Catalog No. A18342 HDAC inhibitorEDO-S101 is a pan HDAC inhibitor; inhibits HDAC1, HDAC2 and HDAC3 with IC50 values of 9, 9 and 25 nM, respectively. 了解更多 -
Valproic acid
Catalog No. A17323 HDAC inhibitorValproic acid is an HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2; Valproic acid sodium salt is used in the treatment of epilepsy, bipolar disorder and prevention of migraine headaches. 了解更多 -
Tucidinostat (Chidamide)
Catalog No. A17861 HDAC inhibitorTucidinostat is a potent and orally bioavailable HDAC enzymes class I (HDAC1/2/3) and class IIb (HDAC10) inhibitor, with IC50s of 95, 160, 67 and 78 nM, less active on HDAC8 and HDAC11 (IC50s, 733 nM, 432 nM, respectively), and shows no effect on HDAC4/5/6/7/9. 了解更多 -
Ac-Lys-AMC
Catalog No. A18461 fluorescent substrate for HDACAc-Lys-AMC (Hexanamide), also termed MAL, is a fluorescent substrate for histone deacetylase HDACs. 了解更多 -
CHDI-390576
Catalog No. A18899 HDAC inhibitorCHDI-390576, a potent, cell permeable and CNS penetrant class IIa histonedeacetylase (HDAC) inhibitor with IC50s of 54 nM, 60 nM, 31 nM, 50 nM for class IIa HDAC4, HDAC5, HDAC7, HDAC9, respectively, shows >500-fold selectivity over class I HDACs (1, 2, 3) and ~150-fold selectivity over HDAC8 and the class IIb HDAC6 isoform. 了解更多 -
Remetinostat
Catalog No. A12149 HDAC inhibitorRemetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma. 了解更多